| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.301658 |
| P953 | full work available at URL | https://syndication.highwire.org/content/doi/10.1126/science.301658 |
| P698 | PubMed publication ID | 301658 |
| P2093 | author name string | Y. Hosobuchi | |
| J. E. Adams | |||
| R. Linchitz | |||
| P2860 | cites work | Experimental Brain Research | Q13358841 |
| Analgesia produced by brain stimulation: Evidence of a prolonged onset period | Q48558513 | ||
| Pain reduction by focal electrical stimulation of the brain: An anatomical and behavioral analysis | Q48571431 | ||
| Chronic Thalamic Stimulation for the Control of Facial Anesthesia Dolorosa | Q48634866 | ||
| Analgesia from electrical stimulation of the periaqueductal gray matter in the cat: behavioral observations and inhibitory effects on spinal cord interneurons | Q48680321 | ||
| Sensations Evoked by Stimulation in the Midbrain of Man | Q49109061 | ||
| Beta-Endorphin as a potent analgesic by intravenous injection | Q59082605 | ||
| Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands | Q24561925 | ||
| Stereospecific and Nonspecific Interactions of the Morphine Congener Levorphanol in Subcellular Fractions of Mouse Brain | Q24617460 | ||
| Antagonism of Stimulation-Produced Analgesia by Naloxone, a Narcotic Antagonist | Q34168553 | ||
| Analgesia from Electrical Stimulation in the Brainstem of the Rat | Q34229438 | ||
| beta-endorphin is a potent analgesic agent | Q34394408 | ||
| Opioid peptides endorphins in pituitary and brain | Q34468905 | ||
| Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine | Q34647183 | ||
| Purification and properties of enkephalin — The possible endogenous ligand for the morphine receptor | Q34647252 | ||
| Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin | Q35004407 | ||
| Central nervous system mechanisms of analgesia | Q37518923 | ||
| Pain reduction by electrical brain stimulation in man. Part 1: Acute administration in periaqueductal and periventricular sites | Q39581590 | ||
| Observations on the analgesic effects of needle puncture (acupuncture). | Q39585867 | ||
| Pain reduction by electrical brain stimulation in man. Part 2: Chronic self-administration in the periventricular gray matter | Q40649959 | ||
| The synthesis and opiate activity of beta-endorphin | Q43412993 | ||
| Surgery in the Rat during Electrical Analgesia Induced by Focal Brain Stimulation | Q43501389 | ||
| Stimulation-produced Analgesia: Development of Tolerance and Cross-Tolerance to Morphine | Q43516135 | ||
| The analgesic effect of electrical stimulation of the diencephalon and mesencephalon | Q43904014 | ||
| Inability of bats to synthesise L-ascorbic acid | Q44347059 | ||
| Opiate antagonist, naloxone, strongly reduces analgesia induced by stimulation of a raphe nucleus (centralis inferior) | Q44640898 | ||
| Federation Proceedings | Q45106928 | ||
| Structural and conformational relationships between the enkephalins and the opiates | Q48392018 | ||
| C fragment of lipotropin has a high affinity for brain opiate receptors | Q48392026 | ||
| A peptide-like substance from pituitary that acts like morphine. I. Isolation | Q48455187 | ||
| Morphine-like ligand for opiate receptors in human CSF | Q48455196 | ||
| An endogenous morphine-like factor in mammalian brain | Q48455261 | ||
| Analgesia induced by electrical stimulation of the inferior centralis nucleus of the raphe in the cat | Q48458558 | ||
| P433 | issue | 4299 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | electric stimulation therapy | Q65617749 |
| P304 | page(s) | 183-186 | |
| P577 | publication date | 1977-07-01 | |
| 1977-07-08 | |||
| P1433 | published in | Science | Q192864 |
| P1476 | title | Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone | |
| Pain Relief by Electrical Stimulation of the Central Gray Matter in Humans and Its Reversal by Naloxone | |||
| P478 | volume | 197 |
| Q36881859 | A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia. |
| Q41282787 | A mathematical model of the gate control theory of pain |
| Q39186680 | A single thalamic target for deep brain stimulation to treat hemi-body pain syndrome. |
| Q72722361 | A subcortical correlate of P300 in man |
| Q34637931 | Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions |
| Q41638462 | Afferent connections of the rostral medulla of the cat: a neural substrate for midbrain-medullary interactions in the modulation of pain |
| Q34300935 | Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis. |
| Q92927508 | Alterations in brain neurocircuitry following treatment with the chemotherapeutic agent paclitaxel in rats |
| Q42136355 | Analgesia in conjunction with normalisation of thermal sensation following deep brain stimulation for central post-stroke pain. |
| Q40676048 | Analgesic electrical stimulation of the feline nucleus raphe magnus: development of tolerance and its reversal by 5-HTP |
| Q39758983 | Anatomy, physiology, and neuropharmacology of cancer pain |
| Q69402786 | Anterior pretectal stimulation alters the responses of spinal dorsal horn neurones to cutaneous stimulation in the rat |
| Q48450787 | Antinociception produced by microinjection of morphine in the rat periaqueductal gray is enhanced in the foot, but not the tail, by intrathecal injection of alpha1-adrenoceptor antagonists |
| Q35996643 | Appearance of beta-endorphin-like immunoreactivity in human ventricular cerebrospinal fluid upon analgesic electrical stimulation |
| Q90450581 | Applications of dynamic functional connectivity to pain and its modulation |
| Q48788466 | Arcuate nucleus projections to brainstem regions which modulate nociception |
| Q36454451 | Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons? |
| Q39900293 | Are the endorphins active in clinical pain states? Narcotic antagonism in chronic pain patients |
| Q36579382 | Association of neuromyelitis optica with severe and intractable pain. |
| Q90302573 | Attention to breath sensations does not engage endogenous opioids to reduce pain |
| Q39189776 | Behavioral Neurochemistry: Neuroregulators and Behavioral States |
| Q52215556 | Behavioral and immunological events induced by electrical stimulation of the rat midbrain periaqueductal gray region. |
| Q33875446 | Biological mechanisms of acupuncture |
| Q91529223 | Boundary effects of expectation in human pain perception |
| Q38826335 | Brain Stimulation Therapy for Central Post-Stroke Pain from a Perspective of Interhemispheric Neural Network Remodeling |
| Q35947261 | Brain stimulation in the treatment of chronic neuropathic and non-cancerous pain |
| Q48392357 | Brainstem control of visceral afferent pathways in the spinal cord |
| Q72960905 | Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid |
| Q34245455 | Central modulation of pain |
| Q33542904 | Central modulation of pain perception |
| Q41502844 | Central nervous system pathways for pain transmission and pain control: issues relevant to the practicing clinician. |
| Q31165355 | Challenges and opportunities for brainstem neuroimaging with ultrahigh field MRI. |
| Q82028763 | Chapter 15 Descending pain modulation as a component of homeostasis |
| Q82029093 | Chapter 59 Neurosurgical treatment of pain |
| Q39468535 | Chronic precentral stimulation in trigeminal neuropathic pain |
| Q39787526 | Clinical pharmacology of narcotic antagonists |
| Q34259819 | Cochlear nucleus implants |
| Q48165259 | Comparative Physiology of Nociception and Pain. |
| Q40399272 | Control of severe pain in children with terminal malignancy |
| Q48906806 | Cross-tolerance between two brainstem sites supporting stimulation-produced analgesia |
| Q35841801 | Current and future options for the management of phantom-limb pain |
| Q39478998 | Deep Brain Stimulation for the Relief of Chronic Pain |
| Q38140840 | Deep brain stimulation and autonomic control |
| Q38252831 | Deep brain stimulation for chronic pain: intracranial targets, clinical outcomes, and trial design considerations |
| Q82858115 | Deep brain stimulation for neuropathic pain |
| Q38230525 | Deep brain stimulation for pain: distinguishing dorsolateral somesthetic and ventromedial affective targets |
| Q35563378 | Deep brain stimulation for the treatment of intractable pain |
| Q30838899 | Deep brain stimulation of the periaqueductal gray releases endogenous opioids in humans. |
| Q37212984 | Deep brain stimulation: a review of basic research and clinical studies |
| Q36938330 | Deep brain stimulation: indications and evidence. |
| Q55502131 | Deep-brain stimulation |
| Q81092895 | Descending modulation of spinal nociceptive processing |
| Q37042685 | Descending noradrenergic influences on pain |
| Q34993456 | Descending pain modulation and chronification of pain |
| Q52148300 | Detection of changes in the periaqueductal gray matter of patients with episodic migraine using quantitative diffusion kurtosis imaging: preliminary findings. |
| Q48826878 | Dipyrone into the nucleus raphe magnus inhibits the rat nociceptive tail-flick reflex |
| Q34432536 | Disrupted functional connectivity of the periaqueductal gray in chronic low back pain. |
| Q37725898 | Divergent Modulation of Nociception by Glutamatergic and GABAergic Neuronal Subpopulations in the Periaqueductal Gray. |
| Q26751421 | Early life programming of pain: focus on neuroimmune to endocrine communication |
| Q48831226 | Effect of midbrain stimulation on amphetamine-induced stereotypy in rats |
| Q72878447 | Effect of naloxone upon diffuse noxious inhibitory controls (DNIC) in the rat |
| Q41551273 | Effect of transcutaneous electrotherapy on CSF β-endorphin content in patients without pain problems |
| Q92165063 | Effects of Intracerebroventricular and Intra-Arcuate Nucleus Injection of Ghrelin on Pain Behavioral Responses and Met-Enkephalin and β-Endorphin Concentrations in the Periaqueductal Gray Area in Rats |
| Q71560261 | Effects of naloxone on the self-stimulation behavior of the postero-lateral area of the hypothalamus in rats--influence of procedural conditions |
| Q44756316 | Efferent projections of the periaqueductal gray in the rabbit |
| Q51874153 | Electrical Stimulation of the Midbrain Mediates Metastatic Tumor Growth |
| Q44285015 | Electrical stimulation of the centromedian thalamic nucleus in the treatment of convulsive seizures: a preliminary report |
| Q48665475 | Elevated β-Endorphin in Cerebrospinal Fluid After Electrical Brain Stimulation: Artifact of Contrast Infusion? |
| Q60679757 | Emotional and Motivational Pain Processing: Current State of Knowledge and Perspectives in Translational Research |
| Q36345061 | Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy |
| Q38066158 | Endogenous opiates: Through 1978 |
| Q41464592 | Endogenous opioid peptides and the control of pain |
| Q40127299 | Endogenous opioid peptides--the enkephalins and endorphins. |
| Q40133639 | Endogenous opioid peptides: review of physiological, pharmacological and clinical aspects |
| Q39706425 | Endogenous opioids |
| Q36178615 | Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer |
| Q34188796 | Endogenous pain control mechanisms: Review and hypothesis |
| Q48493897 | Endorphin patterns within the headache spectrum disorders |
| Q40138938 | Endorphins and Pain |
| Q47851348 | Endoventricular Deep Brain Stimulation of the Third Ventricle: Proof of Concept and Application to Cluster Headache |
| Q40166164 | Enkephalins and Endorphins Clinical, Pharmacological and Therapeutic Implications |
| Q43456765 | Evaluation of c-Fos immunoreactivity in the rat brainstem nuclei relevant in migraine pathogenesis after electrical stimulation of the trigeminal ganglion. |
| Q72650122 | Evaluation of endorphin content in the CSF of patients with trigeminal neuralgia before and after Gasserian ganglion thermocoagulation |
| Q40243992 | Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia |
| Q48666298 | Exploratory behaviour and aversive thresholds following intra-amygdaloid application of opiates in rats |
| Q38741929 | Facial Pain Update: Advances in Neurostimulation for the Treatment of Facial Pain |
| Q48958219 | Forebrain projections to the periaqueductal gray in the monkey, with observations in the cat and rat. |
| Q37810678 | From descending pain modulation to obesity via the medullary raphe |
| Q36567177 | Funktionelle Elektrostimulation Paraplegischer Patienten. |
| Q47311452 | History of neuroaugmentative procedures |
| Q40249337 | Hormonal and Other Effects of Naltrexone in Normal Men |
| Q37150536 | Human brain stem structures respond differentially to noxious heat |
| Q45795455 | Human periventricular grey somatosensory evoked potentials suggest rostrocaudally inverted somatotopy. |
| Q48234476 | Hypothalamic control of nocireceptive and other neurons in the marginal layer of the dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat. |
| Q47641551 | Hypothalamic deep-brain stimulation: target and potential mechanism for the treatment of cluster headache |
| Q70946152 | Hypothalamic, other diencephalic, and telencephalic neurons that project to the dorsal midbrain |
| Q68473878 | Idazoxan blocks the action of noradrenaline but not spinal inhibition from electrical stimulation of the locus coeruleus and nucleus Kolliker-Fuse of the cat |
| Q34360564 | Imaging the functional connectivity of the Periaqueductal Gray during genuine and sham electroacupuncture treatment |
| Q48507577 | Increase of self-mutilation behavior in forelimb deafferented rats, following stimulation of the dorsal raphe nucleus |
| Q49130987 | Inhibition of primate spinothalamic tract neurons by stimulation in ipsilateral or contralateral ventral posterior lateral (VPLc) thalamic nucleus |
| Q41729304 | Inhibition of spinal cord interneurons by narcotic microinjection and focal electrical stimulation in the periaqueductal gray matter |
| Q48826488 | Inspiratory on-switch evoked by stimulation of mesencephalic structures: a patterned response |
| Q39701915 | Interactions between personal expectations and naloxone: Effects on tolerance to ischemic pain |
| Q34047611 | Intracerebroventricular opiate infusion for refractory head and facial pain |
| Q33823524 | Intrinsic functional connectivity of the periaqueductal gray, a resting fMRI study |
| Q33790272 | Invasive and non-invasive brain stimulation for treatment of neuropathic pain in patients with spinal cord injury: a review |
| Q37935529 | Invasive brain stimulation for the treatment of neuropathic pain |
| Q44348650 | Lack of tolerance in peripheral opioid analgesia in mice |
| Q38583593 | Localization of met-enkephalin-like immunoreactivity within pain-related nuclei of cervical spinal cord, brainstem and midbrain in the cat |
| Q47556174 | Long-Term Results of Deep Brain Stimulation of the Anterior Cingulate Cortex for Neuropathic Pain. |
| Q48296535 | Long-term outcomes of deep brain stimulation for neuropathic pain |
| Q52097483 | Mechanisms of craniofacial pain. |
| Q43312266 | Midbrain stimulation inhibits the micturition, defecation and rhythmic straining reflexes elicited by activation of sacral vesical and rectal afferents in the dog. |
| Q36690164 | Mindfulness-Meditation-Based Pain Relief Is Not Mediated by Endogenous Opioids. |
| Q39227240 | Multi-target neurostimulation for adequate long-term relief of neuropathic and nociceptive chronic pain components |
| Q51864726 | Naloxone does not Antagonize the Anesthetic-Induced Depression of Nociceptor-Driven Spinal Cord Response in Spinal Cats |
| Q51249294 | Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma |
| Q67007922 | Naloxone excites nociceptive units in the lumbar dorsal horn of the spinal cat |
| Q37795475 | Neuroethics of Deep Brain Stimulation for Mental Disorders: Brain Stimulation Reward in Humans |
| Q38221714 | Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safety |
| Q24289416 | Neuroimaging of the periaqueductal gray: state of the field |
| Q38093441 | Neuromodulation and palliative medicine |
| Q30454587 | Neuromodulation for cephalgias |
| Q41687908 | Neuronal populations of the human periaqueductal gray, nucleus lateralis |
| Q34000748 | Neuropathic pain and deep brain stimulation |
| Q41419187 | Neurophysiology of pain and pain modulation. |
| Q38268037 | Neurostimulation for the treatment of axial back pain: a review of mechanisms, techniques, outcomes, and future advances |
| Q72679594 | Neurotransmitters and CNS disease. Pain |
| Q40096848 | New directions in the understanding and management of pain |
| Q36836916 | Newer neurotransmitters in pain control |
| Q48684064 | Non-opiate analgesia induced by carbachol microinjection into the pontine parabrachial region of the cat |
| Q44353018 | Non-opioid pathways suppress pain in humans |
| Q72074910 | Opiate peptides, analgesia, and the neuroendocrine system |
| Q48559115 | Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats |
| Q48603410 | Opiate withdrawal behavior after focal brain stimulation |
| Q44352676 | Opioid actions on mammalian spinal neurons |
| Q39696815 | Opioid peptides in blood and cerebrospinal fluid during acute stress. |
| Q37812535 | Opioid peptides, brain and behaviour: A brief review |
| Q44340288 | Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals. |
| Q35793547 | PAG mu opioid receptor activation underlies sex differences in morphine antinociception |
| Q70432248 | Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials |
| Q39781787 | Pain pathways and mechanisms |
| Q39563243 | Pain relief with interferential therapy |
| Q72742950 | Peptides and Nociception |
| Q34541069 | Peripheral nerve injury induces adult brain neurogenesis and remodelling |
| Q41881489 | Periventricular system lesions and stimulation-produced analgesia |
| Q39379020 | Phantom limb pain relieved with different modalities of central nervous system stimulation: a clinical and functional imaging case report of two patients |
| Q40098738 | Pharmacology of Pain and Analgesia |
| Q40234344 | Pituitary Hormones in Brain: Where, How, and Why? |
| Q36681629 | Positive evidence for P6 acupuncture antiemesis |
| Q37464193 | Post-stroke pain |
| Q48087785 | Reciprocal circuits involved in nitroglycerin-induced neuronal activation of autonomic regions and pain pathways: a double immunolabeling and tract-tracing study |
| Q46731169 | Reciprocal interactions between the human thalamus and periaqueductal gray may be important for pain perception |
| Q30661811 | Reduction in opioid- and cannabinoid-induced antinociception in rhesus monkeys after bilateral lesions of the amygdaloid complex. |
| Q44644919 | Relationship of afferent inputs to the lattice of high NADPH-diaphorase activity in the mouse superior colliculus |
| Q35644990 | Relief of dental pain by ice massage of the hand |
| Q41331014 | Role of polymodal receptors in the acupuncture-mediated endogenous pain inhibitory systems. |
| Q35567638 | Role of radiology in central nervous system stimulation |
| Q28261329 | Rutin antinociception involves opioidergic mechanism and descending modulation of ventrolateral periaqueductal grey matter in rats |
| Q30465785 | Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology |
| Q34239382 | Sex similarities and differences in pain-related periaqueductal gray connectivity |
| Q33735110 | Sing the mind electric - principles of deep brain stimulation |
| Q41367409 | Spinal projections from the midbrain in monkey |
| Q35811910 | State-dependent opioid control of pain |
| Q39526413 | Stimulation of Human Periaqueductal Gray for Pain Relief Increases Immunoreactive β-endorphin in Ventricular Fluid |
| Q38426047 | Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility |
| Q39556326 | Stimulation-produced analgesia in animals: behavioural investigations. |
| Q72846811 | Stimulation-produced analgesia in rats: Assessment by two pain tests and correlation with self-stimulation |
| Q49110694 | Stress reactions and endorphinergic systems |
| Q66699614 | Structure of cholecalciferol derivatives |
| Q38196959 | Studies of PAG/PVG stimulation for pain relief in humans. |
| Q71512224 | Subcortical afferent connections of the amygdala in the monkey |
| Q45169226 | Suppression of appetitive behavior in the rat by naloxone: Lack of effect of prior morphine dependence |
| Q52960527 | Suppression of deprivation-induced food and water intake in rats and mice by naloxone |
| Q48115406 | Supraspinal Control of Ascending Pathways |
| Q36723321 | Surgical Management of Pain |
| Q38756507 | Surgical Neurostimulation for Spinal Cord Injury |
| Q48079575 | Targeting the affective component of chronic pain: a case series of deep brain stimulation of the anterior cingulate cortex. |
| Q37336677 | Temporal filtering of nociceptive information by dynamic activation of endogenous pain modulatory systems |
| Q39154007 | Thalamic Deep Brain Stimulation for Neuropathic Pain: Efficacy at Three Years' Follow-Up |
| Q39511560 | Thalamic EEG recordings in patients with chronic pain |
| Q39555748 | Thalamic relay nucleus stimulation for relief of intractable pain. Clinical results and β-endorphin immunoreactivity in the cerebrospinal fluid |
| Q41386379 | The 5-HT2A receptor potassium-chloride cotransporter 2 signaling pathway in a rat incision pain model |
| Q59809225 | The Contribution of Endogenous Modulatory Systems to TMS- and tDCS-Induced Analgesia: Evidence from PET Studies |
| Q58734248 | The Current State of Deep Brain Stimulation for Chronic Pain and Its Context in Other Forms of Neuromodulation |
| Q72628248 | The Current Status of Analgesic Brain Stimulation |
| Q39577093 | The Emotion of Pain and its Chemistry |
| Q64239561 | The Role of Glutamatergic and Dopaminergic Neurons in the Periaqueductal Gray/Dorsal Raphe: Separating Analgesia and Anxiety |
| Q50748382 | The Role of miR-539 in the Anterior Cingulate Cortex in Chronic Neuropathic Pain. |
| Q41629096 | The ascending input to the midbrain periaqueductal gray of the primate |
| Q37849764 | The biological basis of headache |
| Q42115014 | The effects of intraperitoneal administration of antagonists and development of morphine tolerance on the antinociception induced by stimulating the anterior pretectal nucleus of the rat. |
| Q47211438 | The effects of naloxone and cage size on social play and activity in isolated young rats |
| Q33604494 | The effects on the central nervous system of nitroglycerin--putative mechanisms and mediators. |
| Q39764353 | The management of pain |
| Q34332029 | The mechanism of placebo analgesia |
| Q49014247 | The midbrain periaqueductal gray in the rat, cat, and monkey: A Nissl, Weil, and Golgi analysis |
| Q40882262 | The narcotic antagonist naloxone enhances clinical pain |
| Q36398854 | The nucleus accumbens as a potential target for central poststroke pain |
| Q27011310 | The perception and endogenous modulation of pain |
| Q48168536 | The periaqueductal grey area and control of blood pressure in neurodegeneration. |
| Q36449184 | The role of behavioral scientists in the teaching of pain and anxiety control. |
| Q46610757 | The shoulders of giants upon which we stand--the life and death of Dr. Yoshio Hosobuchi |
| Q40250448 | The suppressant effects of naloxone on food and water intake in the rat |
| Q36602436 | The ultrastructure and synaptic connections of serotonin-immunoreactive terminals in spinal laminae I and II. |
| Q33762802 | Theoretical review: altered pain regulatory systems in chronic pain |
| Q33629307 | Thermal sensitivity is not changed by acute pain or afferent stimulation |
| Q71157978 | Time course and effective sites for inhibition from midbrain periaqueductal gray of spinal dorsal horn neuronal responses to cutaneous stimuli in the cat |
| Q48359592 | Topographic localization of neuropeptide Y mRNA in the monkey brainstem |
| Q38966801 | Tractography Study of Deep Brain Stimulation of the Anterior Cingulate Cortex in Chronic Pain: Key to Improve the Targeting |
| Q45087559 | Transcutaneous electrical nerve stimulation and the reaction to experimental pain in human subjects |
| Q37639082 | Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. |
| Q34653058 | Translational principles of deep brain stimulation |
| Q48180989 | Tryptophan reversal of tolerance to analgesia induced by central grey stimulation |
| Q39338188 | Unexpected Complications of Novel Deep Brain Stimulation Treatments: Ethical Issues and Clinical Recommendations. |
| Q36299592 | Ventromedial medulla: pain modulation and beyond |
| Q71373199 | What we don't know about pain |
| Q81093276 | [Antinociceptive effects of alpha(2)-adrenoceptor agonists ("analgesic" actions in animal experiments)agonists ("analgesic" actions in animal experiments).]. |
| Q81092606 | [The effect of central nervous modulation on the quality of epidural blockade.]. |
| Q70198032 | β-Endorphin-like immunoreactivity increases in human lumbar cerebrospinal fluid following routine metrizamide myelography |
Search more.